• SOL’s revenue for the nine months ended September 30, 2026, rose 10.4% to EUR 1.45 billion.
• Third-quarter revenue growth accelerated to 14%, reaching EUR 498.9 million.
• Technical gases sales increased 7.7% to EUR 714.1 million in the nine-month period.
• Home care revenue climbed 12.6% to EUR 764.3 million, supported by patient growth and acquisitions.
• Third-quarter acquisitions included a 51% stake in Brazil’s IBG Group and full ownership of Denmark’s Nowus Healthcare.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SOL S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 0247-21-2026_TELEBORSA.pdf), on November 12, 2026, and is solely responsible for the information contained therein.